Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sodium acetate + magnesium chloride + sodium gluconate + sodium chloride + potassium chloride is a **balanced crystalloid multi-electrolyte solution** supplied principally as an isotonic intravenous fluid, including Baxter's Plasma-Lyte A and Plasma-Lyte 148 products. The standard Plasma-Lyte A formulation provides sodium, potassium, magnesium, chloride, acetate, and gluconate for water and electrolyte replacement; acetate and gluconate are metabolizable anions that consume hydrogen ions during metabolism and support an alkalinizing effect. It is used as a source of water and electrolytes and as an alkalinizing agent in patients requiring intravenous fluid or electrolyte replacement. Closely matched formulations are also marketed as Physiolyte for sterile irrigation, washing, and rinsing rather than usual parenteral administration. ([dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6ec9e61c-2c26-402f-8604-f446b2e34058))
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on sodium acetate + magnesium chloride + sodium gluconate + sodium chloride + potassium chloride.